CLINICAL_TRIALS
trial_result
· 2023-06-13
Clinical Trial Update: Role of Combined Therapy of Propranolol and Gabapentin in Paroxysmal Sympathetic Hyperactivity in Traumatic Brain Injury [Phase 3]
Summary
A Phase 3 trial evaluating combined propranolol and gabapentin therapy for paroxysmal sympathetic hyperactivity after traumatic brain injury is in progress with…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Zagazig University | Conditions: Traumatic Brain Injury | Phase 3 | Status: UNKNOWN